Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
C$0.01
-66.7%
C$0.01
C$0.01
C$0.09
C$300KN/A114,805 shs719,800 shs
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
$0.00
+100.0%
$0.00
$0.00
$0.00
$241K-1.3519.00 million shs3.67 million shs
Presbia PLC stock logo
LENSF
Presbia
$0.02
$0.02
$0.00
$0.19
$257K5.915,650 shsN/A
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
0.00%0.00%0.00%0.00%0.00%
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
+100.00%-33.33%0.00%-33.33%-81.82%
Presbia PLC stock logo
LENSF
Presbia
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
N/AN/AN/AN/AN/AN/AN/AN/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
0.00
N/AN/AN/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
0.00
N/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
C$122.47M0.00C$0.04 per share0.27C($3.60) per share0.00
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
$10K24.13N/AN/A($0.08) per share0.00
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
N/A-C$2.37N/AN/AN/AN/AN/AN/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
-$2.80MN/A0.00N/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
N/AN/AN/AN/AN/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
1,533.65
0.66
0.04
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/AN/AN/A
Presbia PLC stock logo
LENSF
Presbia
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
N/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
N/A
Presbia PLC stock logo
LENSF
Presbia
N/A

Insider Ownership

CompanyInsider Ownership
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
N/A
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
5.61%
Presbia PLC stock logo
LENSF
Presbia
74.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Le Château Inc. (CTU.V) stock logo
CTU
Le Château Inc. (CTU.V)
N/A29.96 millionN/ANot Optionable
Endonovo Therapeutics, Inc. stock logo
ENDV
Endonovo Therapeutics
11.21 billion1.14 billionNot Optionable
Presbia PLC stock logo
LENSF
Presbia
2017.12 millionN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Top Headlines

View All Headlines
Le Château Inc. (CTU.V) stock logo

Le Château Inc. (CTU.V) CVE:CTU

C$0.01 -0.02 (-66.67%)
As of 10/26/2020

Le Château Inc. operates as a specialty retailer and manufacturer. It designs, develops, manufactures, and sells fashion apparel, accessories, and footwear for women and men. As of January 25, 2020, the company 129 stores, including 12 fashion outlet stores, as well as an e-commerce platform in Canada. It operates its stores under the Le Château brand. The company was formerly known as Château Stores of Canada Ltd. and changed its name to Le Château Inc. in July 2000. Le Château Inc. was founded in 1959 and is headquartered in Montreal, Canada.

Endonovo Therapeutics stock logo

Endonovo Therapeutics OTCMKTS:ENDV

$0.0002 +0.00 (+100.00%)
As of 01:33 PM Eastern

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

Presbia stock logo

Presbia OTCMKTS:LENSF

$0.02 0.00 (0.00%)
As of 10/21/2022

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.